The role of uric acid in stroke: The issue remains unresolved

Neurologist

Volumn 14, Issue 4, 2008, Pages 238-242

  Dimitroula, Hariklia V ^a   Hatzitolios, Apostolos I ^a   Karvounis, Haralambos I ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antioxidant; Cardiovascular risk; Neuroprotection; Stroke; Uric acid

Indexed keywords

ANTIOXIDANT; URIC ACID;

ABSENCE OF SIDE EFFECTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; HUMAN; INCIDENCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; URIC ACID BLOOD LEVEL; ANIMAL; BLOOD; HYPERURICEMIA;

ANIMALS; HUMANS; HYPERURICEMIA; RISK FACTORS; STROKE; URIC ACID;

EID: 51649119584     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31815c666b     Document Type: Review

References (46)

1. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-1190.
2. Sarti C, Rastenyte D, Cepaitis Z, et al. International trends in mortality from stroke, 1968 to 1994. Stroke. 2000;31:1588-1601.
3. Ayala C, Greenlund KJ, Croft JB, et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998. Am J Epidemiol. 2001;154:1057-1063.
4. Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke. The Rotterdam Study. Stroke. 2006; 37:1503-1507.
5. Hozawa A, Folsom AR, Ibrahim H, et al. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis. 2006;187:401-407.
6. Mazza A, Pessina AC, Pavei A, et al. Predictors of stroke mortality in elderly people from the general population. The cardiovascular study in the elderly. Eur J Epidemiol. 2001;17:1097-1104.
7. Lehto S, Niskanen L, Rönnemaa T, et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29:635-639.
8. Wang JG, Staessen JA, Fagard RH, et al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37:1069-1074.
9. Chien KL, Hsu HC, Sung FC, et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis. 2005;183:147-155.
10. Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000;10:403-409.
11. De Leeuw PW, Thijs L, Birkenhäger WH, et al; Systolic hypertension in Europe (Syst-Eur) trial investigators. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur Trial. J Am Soc Nephrol. 2002;13:2213-2222.
12. Sakata K, Hashimoto T, Ueshima H, et al. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged. Eur J Epidemiol. 2001;17:461-468.
13. Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens. 2000;18:1149-1154.
14. Goldberg RJ, Burchfiel CM, Benfante R, et al. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program. Arch Intern Med. 1995;155:686-694.
15. Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men. Eur J Cardiovasc Prev Rehabil. 2004;11:185-191.
16. Gerber Y, Tanne D, Medalie JH, et al. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil. 2006;13:193-198.
17. Hoieggen A, Alderman MH, Kjeldsen SE, et al; for the LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004;65:1041-1049.
18. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14:615-631.
19. Yu ZF, Bruce-Keller AJ, Goodman Y, et al. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res. 1998;53:613-625.
20. Waring WS. Uric acid: an important antioxidant in acute ischaemic stroke. Q J Med. 2002;95:691-693.
21. Chamorro A, Obach V, Cervera A, et al. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke. 2002;33:1048-1052.
22. Chamorro A, Planas AM, Muner DS, et al. Uric acid administration for neuroprotection in patients with acute brain ischemia. Med Hypotheses. 2004;62:173-176.
23. Romanos E, Planas AM, Amaro S, et al. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab. 2007;27:14-20.
24. Amaro S, Soy D, Obach V, et al. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke. 2007;38:2173-2175.
25. Kanellis J, Johnson RJ. Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective. Stroke. 2003;34:1956-1957.
26. Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute isch-emic stroke. Stroke. 2003;34:1951-1956.
27. Leinonen JS, Ahonen JP, Lönnrot K, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. 2000;31:33-39.
28. Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000;31:2295-2300.
29. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischemic stroke. Q J Med. 2002;95:685-690.
30. Seghieri G, Moruzzo D, Fascetti S, et al. Increase in serum uric acid is selectively associated with stroke in type 2 diabetes. Diabetes Care. 2002;25:1095.
31. Newman EJ, Rahman FS, Lees KR, et al. Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev. 2006;22:79-82.
32. Wong KYK, MacWalter RS, Fraser HW, et al. Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J. 2002;23:788-793.
33. Milionis HJ, Kalantzi KJ, Goudevenos JA, et al. Serum uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects. J Int Med. 2005;258:435-441.
34. Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71:1120-1127.
35. Jossa F, Farinaro E, Panico S, et al. Serum uric acid and hypertension: the Olivetti Heart Study. J Hum Hypertens. 1994;8:677-681.
36. Feig DI, Johnson RJ. Hyperyricemia in childhood essential hypertension. Hypertension. 2003;42:247-252.
37. Schlotte V, Sevanian A, Hochstein P, et al. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Radic Biol Med. 1998;25:839-847.
38. Eslami P, Corry DB, Nyby MD, et al. Inhibition of oxidative stress and improvement of nitric oxide production by ACE inhibitors and AT1 receptor blockers in uric acid stimulated vascular smooth muscle cells. Am J Hypertens. 2004;17(suppl 1):S154-S155.
39. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cells proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266:8604-8608.
40. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-1742.
41. Kannelis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287-1293.
42. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275-281.
43. Crouse JR, Toole JF, McKinney WM, et al. Risk factors for exrtacranial carotid artery atherosclerosis. Stroke. 1987;18:990-996.
44. Nieto FJ, Iribarren C, Grossc MD, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000;148:131-139.
45. Cherubini A, Ruggiero C, Polidori MC, et al. Potential markers of oxidative stress in stroke. Free Radic Biol Med. 2005;39:841-852.
46. Terkeltaub RA. Clinical practice: gout. New Engl J Med. 2003;349: 1647-1655.